- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05896644
Eat Well Produce Benefit for Diabetes and Food Insecurity
An Evaluation of Eat Well, a Produce Benefit, for Patients With Diabetes and At-risk for Food Insecurity
The goal of this clinical trial is to assess the impact of participation in Eat Well for diabetes patients who are at risk of food insecurity. The main questions it aims to answer are:
- whether there is a difference in Haemoglobin (Hb) A1c measurements and emergency department (ED) utilization between the Eat Well and control groups up to 18 months post-program completion.
- whether there are differences in cardiometabolic health-related outcomes for Eat Well participants.
Participants in the program will receive gift/debit cards for fruits and vegetables and educational nutrition materials. Researchers will compare Eat Well participants with those only receiving educational materials to see if there are differences in cardiometabolic health outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Connor Drake, PhD
- Phone Number: +1 919 724 2129
- Email: connor.drake@duke.edu
Study Contact Backup
- Name: Susan Spratt, MD
- Phone Number: +1 919 668 5360
- Email: susan.spratt@duke.edu
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- Recruiting
- Duke University Health System
-
Contact:
- Connor Drake, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Be active in the Duke Diabetes Registry in the past 12 months AND
- have had at least one outpatient A1c measurement AND
are at risk for food insecurity as defined by one of the following:
- answered often true or sometimes true on one or both of the food insecurity questions as part of the electronic health record social history section (Maestro Care/ Epic of Verona WI) OR
- answered hard or very hard to the financial stress question as part of the electronic health record social history section (Maestro Care/ Epic of Verona WI) OR
- has Medicaid as insurance payer OR
- lives in Area Deprivation Index (ADI) zip code of 7th decile or harder
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Eat Well
The experimental group will participate in the Eat Well Produce Prescription program, receiving an $80 monthly benefit for eligible produce for 12 months and diabetes education materials through email, including curated nutrition and diet information from the Diabetes Resource Page, consistent with standard of care at Duke University Health System.
|
A program offered by Reinvestment Partners giving clients gift/debit cards that allow the purchase of WIC approved fruits and vegetables.
|
No Intervention: Control
The control group will receive usual care (including diabetes educational materials) without the prescription benefit.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HbA1C
Time Frame: 18 months pre program, during program enrollment, and up to 18 months post program
|
A measure of average blood sugar levels over the past 3 months.
|
18 months pre program, during program enrollment, and up to 18 months post program
|
Change in number of ED Visits
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Number of ED visits throughout the study period
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Outpatient visits
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Number of outpatient visits during the study period
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Hospitalizations
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Number of patient hospitalizations during the study period
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Change in weight
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
|
Change in body mass index (BMI)
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
A measure of body fat based on height and weight.
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Change in cholesterol
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Measure of lipids
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Medication adherence (proportion of days covered)
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Medication adherence will be measured by linking EHR data with Surescripts e-prescription network data.
Surescripts facilitates medication refill information exchange between healthcare organizations and pharmacies.
Adherence will be calculated using the proportion of days covered (PDC) approach
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Change in number of diabetes and hypertension medications
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Change in diabetes and hypertension medication numbers
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Change in blood pressure
Time Frame: up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Systolic and Diastolic blood pressure
|
up to 18 months pre program, during program, and up to 18 months post program enrollment
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00112649
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Eat Well
-
National Institute of Diabetes and Digestive and...St. Louis University; Grace Hill Health Centers, Inc.CompletedDiabetes or Diabetes Prevention
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Michigan State UniversityMichigan Health Endowment FundRecruiting
-
Yale UniversityNational Institute of Nursing Research (NINR)Completed
-
University of ArizonaNot yet recruitingNeoplasms | Cancer SurvivorsUnited States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedBulimia Nervosa | Eating DisordersUnited States
-
New York State Psychiatric InstituteInternational Centre for Diarrhoeal Disease Research, Bangladesh; Fogarty International...Not yet recruiting
-
Weill Medical College of Cornell UniversityHospital for Special Surgery, New York; Rheumatology Research FoundationRecruiting
-
University of PennsylvaniaRecruiting
-
University Health Network, TorontoPatient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Applied... and other collaboratorsActive, not recruitingDysphagiaUnited States, Canada